Thrailkill, K. M., Bunn, R. C., Nyman, J. S., Rettiganti, M. R., Cockrell, G. E., Wahl, E. C., . . . Fowlkes, J. L. (2015). SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice. Bone.
Citação norma ChicagoThrailkill, Kathryn M., R. Clay Bunn, Jeffry S. Nyman, Mallikarjuna R. Rettiganti, Gael E. Cockrell, Elizabeth C. Wahl, Sasidhar Uppuganti, Charles K. Lumpkin, e John L. Fowlkes. "SGLT2 Inhibitor Therapy Improves Blood Glucose but Does Not Prevent Diabetic Bone Disease in Diabetic DBA/2J Male Mice." Bone 2015.
Citação norma MLAThrailkill, Kathryn M., et al. "SGLT2 Inhibitor Therapy Improves Blood Glucose but Does Not Prevent Diabetic Bone Disease in Diabetic DBA/2J Male Mice." Bone 2015.